Premium
Molecularly cloned SHIV‐CN97001: a replication‐competent, R5 simian/human immunodeficiency virus containing env of a primary Chinese HIV‐1 clade C isolate
Author(s) -
Liu Qiang,
Li Yue,
Yang GuiBo,
Dai JieJie,
Ruprecht Ruth M.,
Shao Yiming
Publication year - 2011
Publication title -
journal of medical primatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.31
H-Index - 42
eISSN - 1600-0684
pISSN - 0047-2565
DOI - 10.1111/j.1600-0684.2011.00497.x
Subject(s) - virology , viremia , simian immunodeficiency virus , biology , infectivity , virus , rhesus macaque , immunology
Background The increasing prevalence of human immunodeficiency virus type 1 (HIV‐1) subtype C infection worldwide calls for efforts to develop a relevant animal model for evaluating AIDS candidate vaccines. In China, the prevalent HIV strains comprise a circulating recombinant form, BC (CRF07_BC), in which the envelope belongs to subtype C. Methods To evaluate potential AIDS vaccines targeting Chinese viral strains in non‐human primate models, we constructed a simian/human immunodeficiency virus (SHIV) carrying most of the envelope sequence of a primary HIV‐1 clade C strain isolated from an HIV‐positive intravenous drug user from YunNan province in China. Furthermore, to determine whether in vivo adaptation would enhance the infectivity of SHIV‐CN97001, the parental infectious strain was serially passaged through eight Chinese rhesus macaques. Results Infection of six Chinese rhesus macaques with SHIV‐CN97001 resulted in a low level of viremia and no significant alteration in CD4+ T‐lymphocyte counts. However, the hallmarks of SHIV infectivity developed gradually, as shown by the increasingly elevated peak viremia with each passage. Conclusion These findings establish that the R5‐tropic SHIV‐CN97001/Chinese rhesus macaque model should be very useful for the evaluation of HIV‐1 subtype C vaccines in China.